Product Information
COPAXONE 40 MG/ML SYRINGE is a brand product labeled by Teva Neuroscience, Inc., priced at $540.6590 per ML under NDC 68546032512. Its NADAC has been published 631 times since Jul 23, 2014.
FDA first approved this application on Dec 20, 1996. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the Glatiramer Acetate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
40 mg/mL
Manufacturer
Teva Neuroscience, Inc.NDC
68546032512
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
GLATIRAMER ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA020622FDA Approved
12/20/1996
TE Code
AP
On Market Since
1/29/2014
Price Statistics
The NADAC for COPAXONE 40 MG/ML SYRINGE has been published 631 times since Jul 23, 2014, and over the history we have for it it has risen 45.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $540.6590 per ML |
|---|---|
| All-time high | $541.7390 (May 13, 2026) |
| All-time low | $371.9568 (Jul 23, 2014) |
| 52-week high | $541.7390 |
| 52-week low | $495.1664 |
| Median price | $471.3698 |
| Average price | $463.6728 |
| Largest weekly change | +9.4% (Jan 7, 2026) |
| Weeks tracked | 631 |
| Tracking since | Jul 23, 2014 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 83% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of COPAXONE 40 MG/ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for COPAXONE 40 MG/ML SYRINGE, manufactured by Teva Neuroscience, Inc., is $540.6590 per ML (NDC 68546032512), effective Aug 19, 2026.
How has the price of COPAXONE 40 MG/ML SYRINGE changed over time?
Over the history we have for it, the NADAC for COPAXONE 40 MG/ML SYRINGE has risen 45.4%. It has been tracked across 631 weekly CMS publications since Jul 23, 2014.
What are the highest and lowest recorded NADAC prices for COPAXONE 40 MG/ML SYRINGE?
Since Jul 23, 2014, the NADAC for COPAXONE 40 MG/ML SYRINGE has ranged from a low of $371.9568 (Jul 23, 2014) to a high of $541.7390 (May 13, 2026), with a median of $471.3698 per ML.
Are there cheaper alternatives to COPAXONE 40 MG/ML SYRINGE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLATOPA 40 MG/ML SYRINGE, is $91.0725 per ML — about 83% below COPAXONE 40 MG/ML SYRINGE.
Who manufactures COPAXONE 40 MG/ML SYRINGE?
COPAXONE 40 MG/ML SYRINGE (NDC 68546032512) is labeled by Teva Neuroscience, Inc., and CMS classifies it as a brand product.